133
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

DOX-loaded mesoporous hydroxyapatite modified by hyaluronic acid can achieve efficient targeted therapy for lung cancer

, , , &
Pages 612-622 | Received 04 Aug 2022, Accepted 18 Feb 2023, Published online: 04 May 2023

References

  • Mahmoudi S, Ghorbani M, Sabzichi M, et al. Targeted hyaluronic acid-based lipid nanoparticle for apigenin delivery to induce Nrf2-dependent apoptosis in lung cancer cells. J Drug Delivery Sci Technol. 2019;49:268–276.
  • Singh A, Venkannagari S, Oh KH, et al. Small molecule inhibitor of NRF2 selectively intervenes therapeutic resistance in KEAP1-Deficient NSCLC tumors. ACS Chem Biol. 2016;11(11):3214–3225.
  • Yan Z, Yang Y, Wei X, et al. Tumor-penetrating peptide mediation: an effective strategy for improving the transport of liposomes in tumor tissue. Mol Pharm. 2014;11(1):218–225.
  • Farokhzad OC, Langer R. Impact of nanotechnology on drug delivery. ACS Nano. 2009;3(1):16–20.
  • Peer D, Karp JM, Hong S, et al. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2007;2(12):751–760.
  • Ganta S, Devalapally H, Shahiwala A, et al. A review of stimuli-responsive nanocarriers for drug and gene delivery. J Control Release. 2008;126(3):187–204.
  • Almutairi FM, Abd-Rabou AA, Mohamed MS. Raloxifene-encapsulated hyaluronic acid-decorated chitosan nanoparticles selectively induce apoptosis in lung cancer cells. Bioorg Med Chem. 2019;27(8):1629–1638.
  • Luo Z, Dai Y, Gao H. Development and application of hyaluronic acid in tumor targeting drug delivery. Acta Pharm Sin B. 2019;9(6):1099–1112.
  • He Q, Pan L, Wang Y, et al. Bioinspired synthesis of Large-Pore, mesoporous hydroxyapatite nanocrystals for the controlled release of large pharmaceutics. Cryst Growth Des. 2015;15(2):723–731.
  • Wang Q, Wang M, Lu X, et al. Effects of atomic-level nano-structured hydroxyapatite on adsorption of bone morphogenetic protein-7 and its derived peptide by computer simulation. Sci Rep. 2017;7(1):15152.
  • Wu Z, Zhao D. Ordered mesoporous materials as adsorbents. Chem Commun (Camb). 2011;47(12):3332–3338.
  • Li D, Liang Z, Chen J, et al. AIE luminogen bridged hollow hydroxyapatite nanocapsules for drug delivery. Dalton Trans. 2013;42(27):9877–9883.
  • Izadi A, Meshkini A, Entezari MH. Mesoporous superparamagnetic hydroxyapatite nanocomposite: a multifunctional platform for synergistic targeted chemo-magnetotherapy. Mater Sci Eng C Mater Biol Appl. 2019;101:27–41.
  • Bagur R, Hajnoczky G. Intracellular Ca(2+) sensing: its role in calcium homeostasis and signaling. Mol Cell. 2017;66(6):780–788.
  • Secondo A, Bagetta G, Amantea D. On the role of Store-Operated calcium entry in acute and chronic neurodegenerative diseases. Front Mol Neurosci. 2018;11:87.
  • Wang Y, Weiss MT, Yin J, et al. Role of the sodium hydrogen exchanger in maitotoxin-induced cell death in cultured rat cortical neurons. Toxicon. 2009;54(2):95–102.
  • Maroto R, De la Fuente MT, Artalejo AR, et al. Effects of Ca2+ channel antagonists on chromaffin cell death and cytosolic Ca2+ oscillations induced by veratridine. Eur J Pharmacol. 1994;270(4):331–339.
  • Sun Y, Chen Y, Ma X, et al. Mitochondria-Targeted hydroxyapatite nanoparticles for selective growth inhibition of lung cancer in vitro and in vivo. ACS Appl Mater Interf. 2016;8(39):25680–25690.
  • Chen D, Dong X, Qi M, et al. Dual pH/redox responsive and CD44 receptor targeting hybrid nano-chrysalis based on new oligosaccharides of hyaluronan conjugates. Carbohydr Polym. 2017;157:1272–1280.
  • Pourjavadi A, Kohestanian M, Streb C. pH and thermal dual-responsive poly(NIPAM-co-GMA)-coated magnetic nanoparticles via surface-initiated RAFT polymerization for controlled drug delivery. Mater Sci Eng C Mater Biol Appl. 2020;108:110418.
  • Liu Y, Zhao L, Xing R, et al. Covalent assembly of amphiphilic Bola-Amino acids into robust and biodegradable nanoparticles for in vitro photothermal therapy. Chem Asian J. 2018;13(22):3526–3532.
  • Abazari R, Mahjoub AR, Ataei F, et al. Chitosan immobilization on Bio-MOF nanostructures: a biocompatible pH-responsive nanocarrier for doxorubicin release on MCF-7 cell lines of human breast cancer. Inorg Chem. 2018;57(21):13364–13379.
  • Wu T, Tan L, Cheng N, et al. PNIPAAM modified mesoporous hydroxyapatite for sustained osteogenic drug release and promoting cell attachment. Mater Sci Eng C Mater Biol Appl. 2016 May;62:888–896.
  • Liu KI, Hsueh YC, Chen HS, et al. Mesoporous TiO2/WO3 hollow fibers with interior interconnected nanotubes for photocatalytic application. J Mater Chem A. 2014;2:5387–5393.
  • Thiripuranthagan S, Radhakrishnan R, Kannan K, et al. Oxidative esterification of furfural over Au-Pd/HAP-T and Au-Ag/HAP-T bimetallic catalysts supported on mesoporous hydroxyapatite nanorods. RSC Adv. 2016;6:45907–45922.
  • Fan Q, Fan F, Xu W, et al. The structural and surface properties of Al-doped hydroxyapatite (Ca5(PO4)3OH) nanorods and their applications for pH-induced drug delivery. J Alloys Compd. 2021;879:160414.
  • Chen Z, Wang C, Chen J, et al. Biocompatible, functional spheres based on oxidative coupling assembly of green tea polyphenols. J Am Chem Soc. 2013;135(11):4179–4182.
  • Tian X, Zhang J, Zhang F, et al. Preparation of anticancer micro-medicine based on quinoline and chitosan with pH responsive release performance. Colloids Surf B Biointerf. 2018;165:278–285.
  • Jadid MFS, Shademan B, Chavoshi R, et al. Enhanced anticancer potency of hydroxytyrosol and curcumin by PLGA-PAA nano-encapsulation on PANC-1 pancreatic cancer cell line. Environ Toxicol. 2021;36(6):1043–1051.
  • Wang J, Wu C, Qin X, et al. NIR-II light triggered nitric oxide release nanoplatform combined chemo-photothermal therapy for overcoming multidrug resistant cancer. J Mater Chem B. 2021;9(6):1698–1706.
  • Lanna EG, Siqueira RP, Machado MGC, et al. Lipid-based nanocarriers co-loaded with artemether and triglycerides of docosahexaenoic acid: effects on human breast cancer cells. Biomed Pharmacother. 2021;134:111114.
  • Tupal A, Sabzichi M, Bazzaz R, et al. Application of a-Tocotrienol-Loaded biocompatible precirol in attenuation of doxorubicin Dose-Dependent behavior in HUH-7 hepatocarcinoma cell line. Nutr Cancer. 2020;72(4):653–661.
  • Bhat M, Jatyan R, Mittal A, et al. Opportunities and challenges of fatty acid conjugated therapeutics. Chem Phys Lipids. 2021;236:105053.
  • Kim J, Mondal SK, Tzeng SY, et al. Poly(ethylene glycol)-poly(beta-amino ester)-based nanoparticles for suicide gene therapy enhance brain penetration and extend survival in a preclinical human glioblastoma orthotopic xenograft model. ACS Biomater Sci Eng. 2020;6(5):2943–2955.
  • Bejjanki NK, Xu H, Xie M. GSH triggered intracellular aggregated-cisplatin-loaded iron oxide nanoparticles for overcoming cisplatin resistance in nasopharyngeal carcinoma. J Biomater Appl. 2021;36(1):45–54.
  • Hou G, Qian J, Xu W, et al. A novel pH-sensitive targeting polysaccharide-gold nanorod conjugate for combined photothermal-chemotherapy of breast cancer. Carbohydr Polym. 2019 May 15;212:334–344.
  • Li TF, Li K, Zhang Q, et al. Dendritic cell-mediated delivery of doxorubicin-polyglycerol-nanodiamond composites elicits enhanced anti-cancer immune response in glioblastoma. Biomaterials. 2018;181:35–52.
  • Xu L, Tong G, Song Q, et al. Enhanced intracellular Ca(2+) nanogenerator for Tumor-Specific synergistic therapy via disruption of mitochondrial Ca(2+) homeostasis and photothermal therapy. ACS Nano. 2018;12(7):6806–6818.
  • Xia Y, Li B, Zhang F, et al. Hydroxyapatite nanoparticles promote mitochondrial-based pyroptosis via activating calcium homeostasis and redox imbalance in vascular smooth muscle cells. Nanotechnology. 2022;33(27):275101.
  • Zhou Z, Zheng C, Liu Y, et al. Chitosan biguanide induced mitochondrial inhibition to amplify the efficacy of oxygen-sensitive tumor therapies. Carbohydr Polym. 2022;295:119878.
  • Yin T, Wu H, Zhang Q, et al. @Au nanoprobe under an alternating magnetic field. NPG Asia Mater. 2017;9(7):e408–e408.
  • Liu J, Zhu C, Xu L, et al. Nanoenabled intracellular calcium bursting for safe and efficient reversal of drug resistance in tumor cells. Am Chem Soc. 2020;20(11):8102–8111.
  • Sun W, Fan J, Wang S, et al. Biodegradable drug-loaded hydroxyapatite nanotherapeutic agent for targeted drug release in tumors. ACS Appl Mater Interfaces. 2018;10(9):7832–7840.
  • Han Y, Ouyang J, Li Y, et al. Engineering H2O2 self-supplying nanotheranostic platform for targeted and imaging-guided chemodynamic therapy. ACS Appl Mater Interfaces. 2020;12(1):288–297.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.